Mechanisms of action for treatments in multiple sclerosis: Does a heterogeneous disease demand a multi-targeted therapeutic approach? Chofflon M BioDrugs. 2005; 19(5):299-308. PMID: 16207071. Abstract CommentRecommendBookmarkWatch